← back to search

Jaegil Kim

BG Medicine (United States) · US
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Lung Cancer Treatments and Mutations, RNA modifications and cancer, Cancer Genomics and Diagnostics, and Occupational and environmental lung diseases.
h-index
24
citations
36,607
works
110
NIH funding
primary concept
email

Recent publications

Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma
Journal of Clinical Oncology 2025cited by 16position: middledoi
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Nature Genetics 2023cited by 181position: middledoi
Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma
Nature Communications 2022cited by 51position: middledoi
High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities
Cancer Research 2022cited by 36position: middledoi
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
European Urology 2019cited by 1,342position: middledoi
The Immune Landscape of Cancer
Immunity 2019cited by 799position: middledoi
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Cell 2018cited by 3,906position: middledoi
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Cell Reports 2018cited by 800position: middledoi
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Cell Reports 2018cited by 511position: middledoi
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
Cell Reports 2018cited by 186position: middledoi
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
Cancer Cell 2017cited by 911position: middledoi
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
Nature Genetics 2017cited by 546position: middledoi
Integrated Molecular Characterization of Uterine Carcinosarcoma
Cancer Cell 2017cited by 441position: middledoi
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
New England Journal of Medicine 2015cited by 3,216position: middledoi
Comprehensive molecular characterization of urothelial bladder carcinoma
Nature 2014cited by 3,041position: middledoi
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Nature 2013cited by 5,691position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Brian A. Van Tine · Jewish Hospital2 papers (2022–2025) · 2 papers (2022–2025)Michael J. Nathenson · World Education2 papers (2022–2025)Sandra P. D’ Angelo · Memorial Sloan Kettering Cancer Center2 papers (2022–2025) · 2 papers (2022–2025)Justin F. Gainor · Harvard University1 papers (2022–2022)Whijae Roh · Pfizer (United States)1 papers (2022–2022)Hongui Cha · Cancer Research UK1 papers (2022–2022)Neeta Somaiah · The University of Texas MD Anderson Cancer Center1 papers (2025–2025)Mendy Miller · Massachusetts Institute of Technology1 papers (2022–2022) · 1 papers (2022–2022)Ya-Fang Chang · GlaxoSmithKline (United States)1 papers (2022–2022)Aisha Hasan · Northwell Health1 papers (2022–2022)Gurpreet S. Kapoor · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2025–2025) · 1 papers (2025–2025)Sunil Suchindran · University of Wisconsin–Madison1 papers (2025–2025)Gad Getz · Broad Institute1 papers (2022–2022)Yifat Geffen · Broad Institute1 papers (2022–2022) · 1 papers (2022–2022)John Glod · National Institutes of Health1 papers (2022–2022)